Tango Therapeutics (TNGX) Cash & Current Investments (2020 - 2025)
Historic Cash & Current Investments for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to $152.8 million.
- Tango Therapeutics' Cash & Current Investments fell 4789.55% to $152.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.8 million, marking a year-over-year decrease of 4789.55%. This contributed to the annual value of $257.9 million for FY2024, which is 2421.07% down from last year.
- As of Q3 2025, Tango Therapeutics' Cash & Current Investments stood at $152.8 million, which was down 4789.55% from $180.8 million recorded in Q2 2025.
- Over the past 5 years, Tango Therapeutics' Cash & Current Investments peaked at $506.1 million during Q3 2021, and registered a low of $53.2 million during Q2 2021.
- For the 5-year period, Tango Therapeutics' Cash & Current Investments averaged around $308.6 million, with its median value being $333.6 million (2023).
- Per our database at Business Quant, Tango Therapeutics' Cash & Current Investments soared by 21268357.94% in 2021 and then tumbled by 4789.55% in 2025.
- Quarter analysis of 5 years shows Tango Therapeutics' Cash & Current Investments stood at $487.5 million in 2021, then dropped by 24.9% to $366.1 million in 2022, then decreased by 7.05% to $340.3 million in 2023, then decreased by 24.21% to $257.9 million in 2024, then crashed by 40.75% to $152.8 million in 2025.
- Its Cash & Current Investments stands at $152.8 million for Q3 2025, versus $180.8 million for Q2 2025 and $216.7 million for Q1 2025.